| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.6437 | 47 |
| GSM780708 | Untreated after 4 days (C2_1) | 52.2157 | 54 |
| GSM780709 | Untreated after 4 days (C3_1) | 53.3868 | 57 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.4753 | 50 |
| GSM780720 | Untreated after 4 days (C2_2) | 56.6604 | 62 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.5998 | 16 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 52.2379 | 55 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.4891 | 34 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 56.7769 | 62 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 58.4689 | 63 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 50.6747 | 51 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.3574 | 38 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 58.2664 | 63 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 54.1169 | 58 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.0209 | 45 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.3622 | 34 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 56.5684 | 61 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 54.3496 | 59 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 54.8541 | 59 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 57.0336 | 62 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.5833 | 47 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 61.0737 | 65 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 50.5576 | 50 |